To develop and deliver novel therapies to patients, Genmab has formed 20 strategic partnerships with biotechnology and pharmaceutical companies. 97% of the share capital and voting rights in Genmab AS, so that through shares and financial instruments they held the voting rights to a total of 3,278,677 shares in Genmab AS, which amounts to 4. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer.
🌍 Genmab (GMAB) - Form 6-K Filing
Filing Date: 2022-07-01
Accepted: 2022-07-01 12:23:53
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: